Alzheimer Prevention Trials (APT) Webstudy
The Alzheimer Prevention Trials (APT) Webstudy is an online registry designed to accelerate enrollment for Alzheimer's disease clinical trials by identifying and tracking individuals who may be at higher risk for developing Alzheimer's dementia.
|Minimum Age||Maximum Age||Gender||Healthy Volunteers|
|50 Years||85 Years||All||Yes|
- Willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk
- Evidence of dementia
After signing up, participants will go online to fill out a brief assessment of their cognitive abilities and complete a 20-minute test to assess their memory and thinking skills. The test will be repeated every 3 months, and participants will have access to their scores.
By tracking changes over time, researchers will identify individuals who may be at higher risk for developing Alzheimer's dementia. Participants may be invited for in-person testing at a clinical site, involving either a brain scan or a lumbar puncture (spinal tap) to look for beta-amyloid, a protein that accumulates abnormally in the brains of people with Alzheimer's disease. If those tests indicate higher risk, the participant may then be notified of clinical trials that he or she would be eligible for.
Participants can take part in the program without volunteering for clinical trials. The online test data will be aggregated for research purposes.
University of Southern California
- National Institute on Aging (NIA)
- Brigham and Women's Hospital
- Cleveland Clinic
|Paul Aisen, MD||Principal Investigator||University of Southern California|
|Reisa Sperling, MD||Principal Investigator||Brigham and Women's Hospital|
|Jeffrey Cummings, MD||Principal Investigator||Cleveland Clinic|
|APT Webstudy Teamemail@example.com|
Alzheimer Prevention Trials Webstudy